was mentioned for its research into immunotherapy.
A study led by Sharon Bober, PhD, showed a half-day educational program can help women, having ovary-removing surgery as a cancer prevention measure, deal with sexual or psychological side effects.
Dr. Paul Nguyen led a study looking at the link between certain prostate cancer treatments and heart-related deaths.
Alexi Wright’s research on the use of hospice in the final days of
ovarian cancer has been published in the Journal of Clinical Oncology.
Tags: EndOfLife, OvarianCancer
Dr. Charles Fuchs led a study published in Nature Genetics that identified in about 20 percent of colorectal and endometrial cancers, a genetic mutation that had been overlooked in recent large, comprehensive gene searches.
Tags: ColonCancer, GynecologicCancers
Todd R. Golub, MD, Margaret A. Shipp, MD, and Bruce M. Spiegelman, PhD, were elected to the Institute of Medicine, a nongovernmental organization that advises the nation on issues related to biomedical science, medicine, and health.
Dr. Alexi Wright led a study that found increasing the use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women.
Dr. Eric Winer commented on a blood test that could reduce the number of women who need chemotherapy after tumor removal surgery.
Cigall Kodach, PhD, spoke about the problems in today’s biology and medicine research on a panel at the Forbes Under 30 Summit.
“Being Mortal” documentary is based on Dr. Atul Gawande’s book “Being Mortal,”
and follows several Dana-Farber patients through the final stages of life.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: